Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are you trying to imply that the SEC problem wont be cleared up before we burn through our money?
I am saying that we will get a JV before diluting the stock to 4 billion, I seriously doubt that you or any one else would think otherwise. IMO most of us here know the litigations need to be resolved and a vote for R/S and up-listing will come up ( Gary mess needs to be addressed to ) if approved the R/S of course will be implemented and we will be up-listed hopefully in a flurry of good news. This is where I suspect the JV to come on board...
IMO We will have a JV soon so I doubt the type of dilution you speak of...
An 80 to 1 R/S was already approved once and I'm sure it will be again!
80 to 1 R/S would bring the float down to 25 million shares from 2 billion, I would say this is quite acceptable and considered a major reverse split.
See why some of us was saying the news wouldn't help the PPS much if released now instead of later? I thought the PPS would run a bit higher and a little longer before drifting back down to the .06 area but inevitably this is what was going to happen with all the shorts and day traders playing around with 2 billion shares while we are still in litigation...
I was thinking the same as they do have a bad track record from the past and they are still in the middle of litigations. The PPS I doubt will go much lower and GR knows this, IMO if you release good news now with all this BS going on the PPS will surly tank back into sub .10 territory where only the day traders and shorts benefit from...
"One patient's vision went from 20/400 to 20/40, said Lanza."
He sure enough did!
Don't know the cost but Gary said ACT would have a JV soon?
He said they can dbl up at the other institutions already approved if the ones they are waiting on don't get approved in the next few weeks?
Lot of nice ingredients but many of them he has shown us before but don't ever seem to produce a final product, not yet anyways...
Advanced Cell Technology Announces 2013 First Quarter Results
MARLBOROUGH, Mass.--(BUSINESS WIRE)--
Advanced Cell Technology, Inc. (“ACT” or the ”Company”; OTCBB: ACTC) a leader in the field of regenerative medicine, announced today its first quarter financial results for the period ended March 31, 2013. The Company reported a loss from operations of $(5.8) million compared to a loss from operations of $(5.4) million in the 2012 first quarter, primarily as a result of higher clinical trial expenses. ACT reported a net loss of $(6.4) million or $(0.00) per share, compared to a loss in the same period in 2012 of $(5.7) million or $(0.00) per share.
Net cash used in operations for the 2013 first quarter was $8.3 million, compared to net cash used in operations of $4.8 million during the same period in 2012. The Company ended the 2013 first quarter with cash and cash equivalents of $4.1 million, compared to $7.2 million as of December 31, 2012, primarily due to higher operating expenses. Cash utilization increased significantly as a result of $2.3 million used to settle litigation related to previously issued debentures. The Company expects cash utilization to return to previous levels in the subsequent quarter.
Highlights from the first quarter of 2013 included:
• Reached the midway point in all three clinical trials in the U.S. and Europe to investigate hESC-derived RPE cells for the treatment of dry AMD and SMD, both forms of macular degeneration. These trials are prospective, open-label studies, designed to determine the safety and tolerability of hESC-derived RPE cells following sub-retinal transplantation into patients with dry AMD or SMD at 12 months, the study’s primary endpoint. With the addition of the new cohort 2a patients, each of the U.S. trials will now enroll a total of 16 patients across the ascending dosage format of 50,000 to 200,000 RPE cells.
• Received Data and Safety Monitoring Board (DSMB) approval to initiate treatment of the third patient cohort in the Company’s three ongoing stem cell clinical trials in the U.S. and Europe. Per each trial’s protocol, the first patient of “cohort 3” was injected in April with 150,000 human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells. This represents a fifty percent increase in the dose of RPE cells as compared to the previously treated cohort of patients. The first patients treated at this escalated dose will be evaluated, with interim DSMB review after six weeks.
• Received DSMB approval to treat additional cohorts of patients with better vision.
• Observed the persistence of visual acuity gains and engraftment of transplanted cells in clinical trial patients with no safety issues reported.
• ACTC announced a settlement agreement resolving litigation associated with previously issued debentures.
• ACT Chief Scientific Officer Dr. Robert Lanza, voted among the top 4 “Most Influential People on Stem Cells.”
“I am pleased by the progress we are making in our clinical trials. The clearance to treat patients with higher doses of RPE cells and to treat patients with greater visual acuity represents significant milestones in our clinical trials,” said Chairman and CEO Gary Rabin. “Treating patients with better vision significantly improves the likelihood that these patients will show a meaningful benefit when we report data later this year.”
Conference Call
The Company will hold a conference call today at 4:30 pm eastern time to discuss the results. Interested parties may access the call live by dialing (888) 264-3177 and using conference ID 14875304. This event is also being streamed via webcast. The webcast is available at http://us.meeting-stream.com/advancedcelltechnology050913. A replay of the call will also be available via the same link. About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the Company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect ACT’S results and other risks and uncertainties are detailed from time to time in the Company’s periodic reports, including the report on Form 10-K for the year ended December 31, 2012. Forward-looking statements are based on the beliefs, opinions, and expectations of the Company’s management at the time they are made, and the Company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the Company’s management at the time they are made, and the Company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. There can be no assurance that the Company’s clinical trials will be successful.
http://finance.yahoo.com/news/advanced-cell-technology-announces-2013-200000328.html
Contact:.
.
Investors:
CEOcast, Inc.
James Young, 212-732-4300
or
Press:
ACT Corporate Communications
Bill Douglass, 646-450-3615
or
Russo Partners
David Schull, 858-717-231
Well no results & I was hoping for a bit of info about if Gary will be continuing as CEO after he gets every thing cleared with ACT past financing debacle or if he planed on staying aboard if so where he See's himself taking ACTC I also hoped to hear about all his unreported share sells...
Couldn't had said it better my self!
Thanks for the info, Yes your assumption is correct PDPI only I thought he owned over 50% but I am sure your correct. I never did like having a Hedge Fund manager in charge of things here I have felt for some time like we have had the fox watching the hen house...
The SEC FORM 4 shows he has 6 million shares left as of January 2013. So he sold around 4 million reported & 12 million unreported for a total of roughly 16 million shares sold and he has 6 million shares on hand still. So that put him close to 22 million total shares and he has sold 3/4 of his holdings.
He sure knows how to build shareholder value and confidence...
I would like to know how much his hedge fund made off of ACTC in that toxic financing mess he was right in the middle of, do you happen to know those numbers Rocky?
What you see is leaches that have attached themselves to the science and Dr. Lanza if he wanted to continue his research and push it forward in the current political and religious environment ( and he did as he is very driven man ) he didn't have much/no choice than to get involved with these type folks!
I just hope in the end every one of us who stuck through this mess will be rewarded but tbh after watching over the last few years how crooked every thing is ( I don't mean with just ACTC the whole market, government mess ) & if this science does what we think, this company will be taken private and our profits will be minimal.
Just my 2 cents...
Think its over 4b now isn't it? You trying to sugar coat it?
Looking like I get to start loading up again soon! Looking back at my post to your doom and gloom comments last time it was in the 6s and 5s and you will see where I loaded up then and sold at .085 If I would had listened to you or DD I would had missed out on a great opportunity and increasing my core position significantly.
Every day I see folks doing stupid things and not protecting their eyes like they think they can go to Wal-Mart and buy another eye or something...
We are funded until 2015 ACTC was not counting on the NIH funding so if they do get anything from NIH would just be a nice bonus!
It might head slowly south for a little while but with all the news expected to come out over the next month or so I bet it wont be head n south for to long! I just hope we can keep the gains when it happens...
Stemcellinvestor is right about the sell on the news buy on the dips. ( I did this with a small side investment ) This strategy has helped me increase my core position significantly over the last few years. Its not so scary when your not playing around with your core position.
Well said Farviewhill, indeed ACTC is a survivor! This stock over the last 5 years has taught me so much about how the bio sector works and how to do better DD its not even funny...
As I stated before this has to be one of the most exciting stocks to follow better than real TV LOL.
Nice luck! This is one of the most exciting penny stocks out there!!
Commentary & Reports For: (OTCQB: ACTC), 46 minutes ago - eTeligis via Comtex
Advanced Cell Technology, Inc. (OTC QB : ACTC) Robert Lanza, M.D., chief scientific officer of ACTC recently stated "They offer the possibility to generate a non-controversial, unlimited source of patient-specific stem cells without embryo destruction. Owing to their short storage time, there is a constant demand for this life-saving blood component. Since platelets don't contain any genetic material, they cannot form tumors, which makes them ideal for the first clinical trial involving the iPS cell technology. We hope to initiate the first clinical trial using these promising cells in 2013." Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC or the "Company"), a leader in the field of regenerative medicine, announced that chairman and CEO Gary Rabin will present at Biotech Showcase 2013 on Tuesday, Jan. 8, in San Francisco.
Get the latest news on ACTC by getting the free full report here: http://www.wallstreetscoop.net/market-scan/?symbol=ACTC
Over 70 million volume not bad at all! We held on to our gains from Fridays spike + some, im looking forward to the next few weeks.
He has bigger fish to fry like covering that short position!
Why the dbl talk one post your saying ACTC is going bk pretty much & to sell and then a few post later your saying this will be in the .06 for years? You are very confused I think or your up to no good!
Either way seems to me if BK or stagnated for years and you truly believed that you wouldn't even be here posting IMO...
Anyone with a short position might think is has some relevance...
I just wanted to pop in and say I had hell getting shares today even though it dipped to my limit price and beyond several times. I did get a few but it was just a nibble compared...
Keep your heads up the ol-timers thats been here with ACTC has seen many 100 to 400% gains easy from the current PPS and to be honest today we are in better shape than any of the past runs so dont fool your self into thinking its not coming!
Just one more thing I would like to mention as I agree 110% something needs to be done about Gary he needs to be paid according to his performance or if he has a problem with that then he should be replaced as our (temp?) CEO & our so called board needs to address this or be replaced as well.
Just my 2 cents
If you see it in the 5s you can be assured I will "Load up" great advise if I say so my self 8)
Happy 4th of July everyone! Happy Birthday U.S. 8)
I bought some .0615s today, I was going to start in the 5s but I'm not so sure it will go there. We need some more gloom % doom investors selling their shares 4 sure. Icell seems to have this idea if they are saying these suits will reach 100 million... The companies that are suing us already made a few million profit off their 1 million investment to say a judge is going to award them another 100 million profit like a cherry on top well its just funny at best and a scare tactic!
I am locked and loaded my self!
That just sounds outrageous 100,000,000,00 come on even the 65 million is way over the top! From what I can gather its more like 3.5 million best case scenario to 10 million worse case.
Where in the world do they get 100 million from I wonder?
Elichen for one my statement is pretty much hinging on conspiracy theory issues. I believe our country our government is bought and paid for by big corporations like big pharmaceutical company's, banks,
GS, JPM etc who are in full control.
I can give you an example look at six flags it was just stolen from its investors, the company was devalued .from 2 billion to 800 million and filed BK, the company come out of BK worth about 1.6 billion. Now SIX is worth about 2.8 billion in just one year but almost fully owned by the banks and hedge funds they are trying to get investors to buy their way over valued stock that they have been trading back and fourth and offering attractive divy. SIX PPS 51.56
- Income is 9.5 M$ on 1,020 M$ in sales
- Forward P/E of 32
- Price / Book of 4.39
- Long Term Debt / Equity of 145%
- Dividend Payout Ratio of 428%
- Return on Equity of 1.4%
As you can see divy or any thing else here don't look to solid for the investor. Sells are about the same yet the company is worth over 3x what they claimed it was worth before BK. How can our government or even the Judge in the BK for that matter let this kind of stuff happen if it wasn't conspiracy to steal the company?
Far as my comment on Gary, well Gary was a hedge fund manager who was involved in some of our toxic financing and his hedge fund is one of the settlements recipients. Hedge funds are experts at toxic finance and sweeping up crushed company's from shorting to toxic finance. Now one of the Hedge Funds who already took us for a ride is running the company... What would you think?
Thanks PennyNK! Its always nice to take a plunge with a friend or two lol. Really though this will bounce back but its a real bio-stock company it takes time for trials etc, not some penny scam that one hopes to make instant profits off of while leaving the guy late to the party holding the bag.
My biggest worry is Big Money smashing us and stealing ACTC out from under us and it almost seems GR might be the fox in the hens house...
Elysse I read your stuff all the time here and enjoy reading your thoughts. I am spooked as well but I have been here before with ACTC ( PPS ) I kept the faith and it did turn around, this is a bit different now I know, but I am in for the long haul!!
If its the right thing to do I have no idea, I do know I have seen profits here many times and always failed to cash in or take advantage as I believe in the science and in Dr. Lanza so I just keep adding at the lower PPS as it presents its self. I might be being foolish but I am learning... ( the hard way! )
Looks like they are saving the .05s for tomorrow...
I will be buying in 5s down, 4 years here guess I will just sink with the ship!
I will be accumulating anything under .058!
Worthless patents? Please explain why you think they are worthless. Sometimes I think you just toss crap on the wall to see what sticks...
"The people only break the law when they benefit from the company's illegal activity"
So what you saying? That if we had stock in the company when this happen that we benefited as stock holders some how??